Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. (August 2018) - Papageorgiou, Sotirios G.; Kotsianidis, Ioannis; Kontos, Christos K.; Symeonidis, Argyris; Galanopoulos, Athanasios; Hatzimichael, Eleftheria; Poulakidas, Elias; Diamantopoulos, Panagiotis; Vassilakopoulos, Theodoros P.; Zikos, Panagiotis; Papadaki, Helen; Bouronikou, Eleni; et al.